Balyasny Asset Management’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $208K | Sell |
|
|||||
|
2023
Q3 | $656K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.48M | Sell |
|
|||||
|
2022
Q4 | $2.34M | Sell |
|
|||||
|
2022
Q3 | $7.69M | Sell |
|
|||||
|
2022
Q2 | $7.81M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $214K | Sell |
|
|||||
|
2019
Q2 | $5.02M | Sell |
|
|||||
|
2019
Q1 | $4.81M | Buy |
|
|||||
|
2018
Q4 | $824K | Buy |
|
|||||
|
2018
Q3 | $921K | Sell |
|
|||||
|
2018
Q2 | $4.49M | Buy |
|
|||||
|
2018
Q1 | $163K | Buy |
|